HomeDYN • NASDAQ
Dyne Therapeutics Inc
add
$11.62
0.00%
Pre-market:(0.17%)+0.020
$11.64
Closed: Aug 13, 8:39:19 AM UTC-4 · USD · NASDAQ · Disclaimer
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 115.79M | 60.91% |
Net income | -110.86M | -70.28% |
Net profit margin | — | — |
Earnings per share | -0.97 | -38.57% |
EBITDA | -115.29M | -61.10% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 683.93M | -12.19% |
Total assets | 728.99M | -11.73% |
Total liabilities | 157.55M | 210.80% |
Total equity | 571.45M | — |
Shares outstanding | 142.26M | — |
Price to book | 2.32 | — |
Return on assets | -39.93% | — |
Return on capital | -41.81% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -110.86M | -70.28% |
Cash from operations | -94.70M | -72.60% |
Cash from investing | 6.77M | -39.38% |
Cash from financing | 100.77M | -73.47% |
Net change in cash | 12.85M | -96.18% |
Free cash flow | -55.78M | -445.80% |
Previous close
$11.62
Year range
$6.36 - $47.45
Market cap
1.65B USD
Avg Volume
3.48M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2017
Headquarters
Website
Employees
206
